{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:42:23Z","timestamp":1791902543377,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]},{"name":"Ministry of Health Malaysia research grant","award":["NMRR ID-22-00187-DJU"],"award-info":[{"award-number":["NMRR ID-22-00187-DJU"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>High-risk human papillomavirus (HPV) screening is vital for early cervical cancer detection and treatment. With the introduction of the national cervical cancer screening programme and screening registry in Malaysia, there is a need to monitor population-based HPV screening uptake and high-risk HPV prevalence as part of cervical cancer surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the prevalence and sociodemographic factors predicting high-risk HPV infection in Malaysia based on a public, community-based cervical cancer screening registry targeting women at risk of getting HPV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study used data from the Malaysian cervical cancer screening registry established by the Family Health Development Division from 2019 to 2021. The registry recorded sociodemographic data, HPV test details and results of eligible women who underwent HPV screening at public primary healthcare facilities. A vaginal sample (via self-sampling or assisted by a healthcare provider) was used for DNA extraction for HPV detection and genotyping. Registry data were extracted and analysed to determine prevalence estimates of high-risk HPV infection. Multifactorial logistic regression analysis was conducted to determine predictors of high-risk HPV infection. All analyses were performed using Stata version 14.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The programme screened a total of 36,738 women during the study period. Women who attended the screening programme were mainly from urban areas, aged 30\u201339 years, and of Malay ethnicity. The prevalence of high-risk HPV infection was 4.53% among women screened, with the yearly prevalence ranging from 4.27 to 4.80%. A higher prevalence was observed among urban settling women, those aged 30\u201349 years, those of Indian ethnicity, and those without children. The results from logistic regression showed that women from urban areas, lower age groups, of Indian or Chinese ethnicity, and who are self-employed were more likely to be infected with high-risk HPV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Targeted and robust strategies to reach identified high-risk groups are needed in Malaysia. In addition, the registry has the potential to be expanded for an improved cervical cancer elimination plan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Trial registration number: NMRR ID-22-00187-DJU.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-023-17132-2","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T04:02:24Z","timestamp":1699934544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry"],"prefix":"10.1186","volume":"23","author":[{"given":"Anis-Syakira","family":"Jailani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Zahirah","family":"Balqis-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar Foong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng Hong","family":"Fun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazimah Abdul","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohaidza","family":"Jahaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurun Najihah","family":"Subakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roziah","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakiah Mohd","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondi","family":"Sararaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"17132_CR1","volume-title":"Global cancer observatory: cancer today","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer; 2018."},{"key":"17132_CR2","doi-asserted-by":"publisher","first-page":"106322","DOI":"10.1016\/j.ypmed.2020.106322","volume":"144","author":"PE Gravitt","year":"2021","unstructured":"Gravitt PE, Silver MI, Hussey HM, Arrossi S, Huchko M, Jeronimo J, et al. Achieving equity in cervical cancer screening in low-and middle-income countries (LMICs): strengthening health systems using a systems thinking approach. Prev Med. 2021;144:106322.","journal-title":"Prev Med"},{"issue":"1","key":"17132_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-10013-y","volume":"21","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the global burden of disease study 2019. BMC Public Health. 2021;21(1):1\u201310.","journal-title":"BMC Public Health"},{"issue":"2","key":"17132_CR4","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Glob Health"},{"issue":"21","key":"17132_CR5","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1002\/cncr.33795","volume":"127","author":"S Lin","year":"2021","unstructured":"Lin S, Gao K, Gu S, You L, Qian S, Tang M, et al. Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer. 2021;127(21):4030\u20139.","journal-title":"Cancer"},{"key":"17132_CR6","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem.\u00a0Geneva: World Health Organization (WHO); 2020. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"17132_CR7","doi-asserted-by":"crossref","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of Cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2022. Supplementary appendix pp 10 & 14.","DOI":"10.1016\/S2214-109X(22)00501-0"},{"key":"17132_CR8","volume-title":"Malaysia national cancer registry report 2012\u20132016.\u00a0 Malaysia cancer statistics, data and figure","author":"A Azizah","year":"2019","unstructured":"Azizah A, Hashimah B, Nirmal K, Siti Zubaidah A, Puteri N, Nabihah A, et al. Malaysia national cancer registry report 2012\u20132016.\u00a0 Malaysia cancer statistics, data and figure. 2019."},{"key":"17132_CR9","volume-title":"Action plan towards the elimination of cervical cancer in Malaysia 2021\u20132030","author":"Family Health Development Division MoHM","year":"2021","unstructured":"Family Health Development Division MoHM. Action plan towards the elimination of cervical cancer in Malaysia 2021\u20132030. 2021."},{"key":"17132_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S2055-6640(20)30063-7","volume":"5","author":"Y Woo","year":"2019","unstructured":"Woo Y. The feasibility and acceptability of self-sampling and HPV testing using Cepheid Xpert\u00ae HPV in a busy primary care facility. J Virus Eradication. 2019;5:10\u20131.","journal-title":"J Virus Eradication"},{"issue":"1","key":"17132_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1158\/1940-6207.CAPR-20-0280","volume":"14","author":"SP Khoo","year":"2021","unstructured":"Khoo SP, Lim WT, Rajasuriar R, Nasir NH, Gravitt P, Woo YL. The acceptability and preference of vaginal self-sampling for human papillomavirus (HPV) testing among a multi-ethnic asian female population. Cancer Prev Res. 2021;14(1):105\u201312.","journal-title":"Cancer Prev Res"},{"issue":"3","key":"17132_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ijc.30695","volume":"141","author":"AK Mezei","year":"2017","unstructured":"Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, et al. Cost-effectiveness of cervical cancer screening methods in low\u2010and middle\u2010income countries: a systematic review. Int J Cancer. 2017;141(3):437\u201346.","journal-title":"Int J Cancer"},{"issue":"10","key":"17132_CR13","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.3390\/curroncol29100579","volume":"29","author":"YL Woo","year":"2022","unstructured":"Woo YL, Khoo SP, Gravitt P, Hawkes D, Rajasuriar R, Saville M. The implementation of a primary HPV self-testing cervical screening program in Malaysia through Program ROSE\u2014Lessons Learnt and moving Forward. Curr Oncol. 2022;29(10):7379\u201387.","journal-title":"Curr Oncol"},{"key":"17132_CR14","volume-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2021."},{"key":"17132_CR15","volume-title":"Guidelines for primary HPV testing in cervical cancer screening in Malaysia","author":"Family Health Development Division MoHM","year":"2019","unstructured":"Family Health Development Division MoHM. Guidelines for primary HPV testing in cervical cancer screening in Malaysia. 2019."},{"key":"17132_CR16","doi-asserted-by":"crossref","unstructured":"Keane A, Ng CW, Simms K, Nguyen D, Woo Y, Saville M, et al. The road to Cervical cancer elimination in Malaysia: evaluation of the impact and cost-effectiveness of HPV screening with self-collection and digital registry support. Int J Cancer. 2021.","DOI":"10.1002\/ijc.33759"},{"issue":"1","key":"17132_CR17","doi-asserted-by":"publisher","first-page":"c17","DOI":"10.1159\/000286345","volume":"115","author":"M Noordzij","year":"2010","unstructured":"Noordzij M, Dekker FW, Zoccali C, Jager KJ. Measures of disease frequency: prevalence and incidence. Nephron Clin Pract. 2010;115(1):c17\u201320.","journal-title":"Nephron Clin Pract"},{"issue":"12","key":"17132_CR18","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 M, Ferrer E, Bosch FX, de Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399.","journal-title":"J Infect Dis"},{"issue":"15","key":"17132_CR19","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.7314\/APJCP.2014.15.15.6151","volume":"15","author":"K Paengchit","year":"2014","unstructured":"Paengchit K, Kietpeerakool C, Lalitwongsa S. Prevalence and genotype distribution of HPV among women attending a cervical cancer screening mobile unit in Lampang, Thailand. Asian Pac J Cancer Prev. 2014;15(15):6151\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"14","key":"17132_CR20","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/0956462414528315","volume":"25","author":"SK Tay","year":"2014","unstructured":"Tay SK, Oon LLE. Prevalence of cervical human papillomavirus Infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study. Int J STD AIDS. 2014;25(14):1013\u201321.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"17132_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-015-0172-7","volume":"15","author":"LT-H Tran","year":"2015","unstructured":"Tran LT-H, Tran LT, Bui TC, Le DT-K, Nyitray AG, Markham CM, et al. Risk factors for high-risk and multi-type human papillomavirus Infections among women in Ho Chi Minh City, Vietnam: a cross-sectional study. BMC Womens Health. 2015;15(1):1\u20139.","journal-title":"BMC Womens Health"},{"issue":"4","key":"17132_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/sextrans-2017-053320","volume":"94","author":"SP Khoo","year":"2018","unstructured":"Khoo SP, Bhoo-Pathy N, Yap SH, Shafii MKA, Nasir NH, Belinson J, et al. Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population. Sex Transm Infect. 2018;94(4):277\u201383.","journal-title":"Sex Transm Infect"},{"issue":"5","key":"17132_CR23","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.7314\/APJCP.2014.15.5.2245","volume":"15","author":"N Othman","year":"2014","unstructured":"Othman N, Othman NH. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation. Asian Pac J Cancer Prev. 2014;15(5):2245\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"17132_CR24","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.31557\/APJCP.2021.22.9.2969","volume":"22","author":"F Rahmat","year":"2021","unstructured":"Rahmat F, Kuan JY, Hajiman Z, Shakrin NNSM, Roos NAC, Mustapa M, et al. Human papillomavirus (HPV) prevalence and type distribution in Urban areas of Malaysia. Asian Pac J Cancer Prev. 2021;22(9):2969.","journal-title":"Asian Pac J Cancer Prev"},{"key":"17132_CR25","volume-title":"Malaysian health system review","author":"S Jaafar","year":"2012","unstructured":"Jaafar S, Noh KM, Muttalib KA, Othman NH, Healy J. Malaysian health system review. 2012."},{"issue":"6","key":"17132_CR26","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1128\/JCM.00883-14","volume":"52","author":"M Cui","year":"2014","unstructured":"Cui M, Chan N, Liu M, Thai K, Malaczynska J, Singh I, et al. Clinical performance of Roche Cobas 4800 HPV test. J Clin Microbiol. 2014;52(6):2210\u20131.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"17132_CR27","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1128\/JCM.05552-11","volume":"49","author":"D Heideman","year":"2011","unstructured":"Heideman D, Hesselink A, Berkhof J, Van Kemenade F, Melchers W, Daalmeijer NF, et al. Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol. 2011;49(11):3983\u20135.","journal-title":"J Clin Microbiol"},{"key":"17132_CR28","unstructured":"eStatistics. 2022. Available from: https:\/\/newss.statistics.gov.my\/newss-portalx\/ep\/epProductPublicationSearch.seam. Cited 19 Dec 2022."},{"issue":"1","key":"17132_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(1):1\u20138.","journal-title":"Source Code Biol Med"},{"key":"17132_CR30","volume-title":"Regression methods in biostatistics: linear, logistic, survival, and repeated measures models","author":"E Vittinghoff","year":"2006","unstructured":"Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. Regression methods in biostatistics: linear, logistic, survival, and repeated measures models. 2006."},{"issue":"4","key":"17132_CR31","first-page":"203","volume":"19","author":"A-M \u0160imundi\u0107","year":"2009","unstructured":"\u0160imundi\u0107 A-M. Measures of diagnostic accuracy: basic definitions. EJIFCC. 2009;19(4):203.","journal-title":"EJIFCC"},{"issue":"1","key":"17132_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1536867X0600600106","volume":"6","author":"KJ Archer","year":"2006","unstructured":"Archer KJ, Lemeshow S. Goodness-of-fit test for a logistic regression model fitted using survey sample data. Stata J. 2006;6(1):97\u2013105.","journal-title":"Stata J"},{"issue":"20","key":"17132_CR33","doi-asserted-by":"publisher","first-page":"13663","DOI":"10.3390\/ijerph192013663","volume":"19","author":"J Anis-Syakira","year":"2022","unstructured":"Anis-Syakira J, Jawahir S, Abu Bakar NS, Mohd Noh SN, Jamalul-Lail NI, Hamidi N, et al. Factors affecting the use of private outpatient services among the adult population in Malaysia. Int J Environ Res Public Health. 2022;19(20):13663.","journal-title":"Int J Environ Res Public Health"},{"key":"17132_CR34","unstructured":"Institut Kesihatan Umum IKN. National Health Morbidity Survey 2019. Malaysia; 2019."},{"issue":"1","key":"17132_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-019-0785-3","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Tang D, Wang K, Wang J, Zhang Z, Chen Y, et al. HPV genotype prevalence and distribution during 2009\u20132018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health. 2019;19(1):1\u201314.","journal-title":"BMC Womens Health"},{"issue":"3","key":"17132_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/0019-5154.182410","volume":"61","author":"MS Setia","year":"2016","unstructured":"Setia MS. Methodology series module 3: cross-sectional studies. Indian J Dermatol. 2016;61(3):261.","journal-title":"Indian J Dermatol"},{"issue":"5","key":"17132_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019244","volume":"6","author":"SS Liu","year":"2011","unstructured":"Liu SS, Chan KYK, Leung RCY, Chan KKL, Tam KF, Luk MHM, et al. Prevalence and risk factors of human papillomavirus (HPV) Infection in southern Chinese women\u2013a population-based study. PLoS One. 2011;6(5): e19244.","journal-title":"PLoS One"},{"issue":"2","key":"17132_CR38","first-page":"303","volume":"10","author":"NA Sharifah","year":"2009","unstructured":"Sharifah NA, Seeni A, Nurismah M, Clarence-Ko C, Hatta A, Ho N-P, et al. Prevalence of human papillomavirus in abnormal cervical smears in Malaysian patients. Asian Pac J Cancer Prev. 2009;10(2):303\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"17132_CR39","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.52711\/0974-360X.2021.00481","volume":"14","author":"MS Yi","year":"2021","unstructured":"Yi MS, Siang TC, Lwin S, Myint KT, Yee KT, Lwin N, et al. Prevalence of human papilloma virus in women with abnormal cervical smears from sarawak, Malaysia. Res J Pharm Technol. 2021;14(5):2729\u201334.","journal-title":"Res J Pharm Technol"},{"issue":"2","key":"17132_CR40","first-page":"79","volume":"68","author":"T Harano","year":"2014","unstructured":"Harano T, Okada S. Prevalence of high-risk human papillomavirus (HR-HPV) Infection among women with normal and abnormal cervical cytology in Myanmar. Acta Med Okayama. 2014;68(2):79\u201387.","journal-title":"Acta Med Okayama"},{"issue":"7","key":"17132_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S De Sanjos\u00e9","year":"2007","unstructured":"De Sanjos\u00e9 S, Diaz M, Castellsagu\u00e9 X, Clifford G, Bruni L, Mu\u00f1oz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"17132_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ajog.2012.11.020","volume":"208","author":"JT Cox","year":"2013","unstructured":"Cox JT, Castle PE, Behrens CM, Sharma A, Wright TC Jr, Cuzick J, et al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study. Am J Obstet Gynecol. 2013;208(3):184 e1-. e11.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"17132_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-207","volume":"14","author":"F Sultana","year":"2014","unstructured":"Sultana F, English DR, Simpson JA, Brotherton JM, Drennan K, Mullins R, et al. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never-and under-screened women in Australia. BMC Cancer. 2014;14(1):1\u201311.","journal-title":"BMC Cancer"},{"issue":"11","key":"17132_CR44","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S De Sanjose","year":"2010","unstructured":"De Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"issue":"7","key":"17132_CR45","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/cncr.32003","volume":"125","author":"K Li","year":"2019","unstructured":"Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125(7):1030\u20137.","journal-title":"Cancer"},{"issue":"1","key":"17132_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-022-01879-y","volume":"19","author":"X Li","year":"2022","unstructured":"Li X, Xiang F, Dai J, Zhang T, Chen Z, Zhang M, et al. Prevalence of cervicovaginal human papillomavirus Infection and genotype distribution in Shanghai, China. Virol J. 2022;19(1):1\u20139.","journal-title":"Virol J"},{"issue":"10","key":"17132_CR47","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1038\/sj.bjc.6604324","volume":"98","author":"A Sargent","year":"2008","unstructured":"Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, et al. Prevalence of type-specific HPV Infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer. 2008;98(10):1704\u20139.","journal-title":"Br J Cancer"},{"key":"17132_CR48","volume-title":"Marriage and divorce statistics, Malaysia","author":"Malaysia DoS","year":"2020","unstructured":"Malaysia DoS. Marriage and divorce statistics, Malaysia. 2020."},{"key":"17132_CR49","volume-title":"Comprehensive cervical cancer control: a guide to essential practice","author":"WH Organization","year":"2006","unstructured":"Organization WH, Health WHOR, Diseases WHOC, Promotion H. Comprehensive cervical cancer control: a guide to essential practice. Switzerland: World Health Organization; 2006."},{"issue":"7","key":"17132_CR50","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/aje\/kwt077","volume":"178","author":"MA Vink","year":"2013","unstructured":"Vink MA, Bogaards JA, van Kemenade FJ, de Melker HE, Meijer CJ, Berkhof J. Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical Cervical cancer from doubly censored national registry data. Am J Epidemiol. 2013;178(7):1161\u20139.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"17132_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/00224490802624414","volume":"46","author":"O Kontula","year":"2009","unstructured":"Kontula O, Haavio-Mannila E. The impact of aging on human sexual activity and sexual desire. J Sex Res. 2009;46(1):46\u201356.","journal-title":"J Sex Res"},{"key":"17132_CR52","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bjid.2017.01.009","volume":"21","author":"Z Baloch","year":"2017","unstructured":"Baloch Z, Yasmeen N, Li Y, Ma K, Wu X, Yang S-h, et al. Prevalence and risk factors for human papillomavirus Infection among Chinese ethnic women in southern of Yunnan, China. Brazilian J Infect Dis. 2017;21:325\u201332.","journal-title":"Brazilian J Infect Dis"},{"issue":"1","key":"17132_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5334\/aogh.2502","volume":"85","author":"MB Ilisiu","year":"2019","unstructured":"Ilisiu MB, Hashim D, Andreassen T, St\u00f8er NC, Nicula F, Weiderpass E. HPV testing for cervical cancer in Romania: high-risk hpv prevalence among ethnic subpopulations and regions. Ann Global Health. 2019;85(1):89.","journal-title":"Ann Global Health."},{"issue":"11","key":"17132_CR54","doi-asserted-by":"publisher","first-page":"e012753","DOI":"10.1136\/bmjopen-2016-012753","volume":"6","author":"T Akinyemiju","year":"2016","unstructured":"Akinyemiju T, Ogunsina K, Sakhuja S, Ogbhodo V, Braithwaite D. Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO\u2019s study on Global Ageing and Adult Health (SAGE). BMJ Open. 2016;6(11):e012753.","journal-title":"BMJ Open"},{"issue":"8","key":"17132_CR55","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/sextrans-2013-051384","volume":"90","author":"DT Geraets","year":"2014","unstructured":"Geraets DT, Gr\u00fcnberg AW, van der Helm JJ, van der Loeff MFS, Quint KD, Sabajo LO, et al. Cross-sectional study of genital carcinogenic HPV Infections in Paramaribo, Suriname: prevalence and determinants in an ethnically diverse population of women in a pre-vaccination era. Sex Transm Infect. 2014;90(8):627\u201333.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"17132_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/01.AOG.0000266984.23445.9c","volume":"110","author":"JA Kahn","year":"2007","unstructured":"Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus Infection. Obstet Gynecol. 2007;110(1):87\u201395.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"17132_CR57","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1080\/21645515.2019.1689743","volume":"16","author":"J Yang","year":"2020","unstructured":"Yang J, Wang W, Wang Z, Wang Z, Wang Y, Wang J, et al. Prevalence, genotype distribution and risk factors of cervical HPV Infection in Yangqu, China: a population-based survey of 10086 women. Hum Vaccin Immunother. 2020;16(7):1645\u201352.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"17132_CR58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.21315\/mjms2019.26.4.9","volume":"26","author":"NSA Bakar","year":"2019","unstructured":"Bakar NSA, MAnuAl A, Ab HAMid J. Socioeconomic status affecting inequity of healthcare utilisation in Malaysia. Malays J Med Sci. 2019;26(4):79.","journal-title":"Malays J Med Sci"},{"issue":"1","key":"17132_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-021-06656-1","volume":"21","author":"N Hamidi","year":"2021","unstructured":"Hamidi N, Tan Y, Jawahir S, Tan EH. Determinants of community pharmacy utilisation among the adult population in Malaysia: findings from the National Health and Morbidity Survey 2019. BMC Health Serv Res. 2021;21(1):1\u201311.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"17132_CR60","doi-asserted-by":"publisher","first-page":"e0278477","DOI":"10.1371\/journal.pone.0278477","volume":"17","author":"SP Khoo","year":"2022","unstructured":"Khoo SP, Muhammad Ridzuan Tan NA, Rajasuriar R, Nasir NH, Gravitt P, Ng CW, et al. Changes in genital human papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program. PLoS One. 2022;17(12):e0278477.","journal-title":"PLoS One"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17132-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-17132-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17132-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T19:41:48Z","timestamp":1730490108000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-17132-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["17132"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-17132-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"assertion":[{"value":"21 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to correct a typo and the supplementary files.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was part of an extensive study titled \u2018Cervical Cancer Screening: Simulation of Best Practices to Achieve the Target\u2019 with trial registration number NMRR ID-22-00187-DJU. The study was approved by the Medical Research and Ethics Committee (MREC), Ministry of Health (KKM, NIHSEC, 22-00187-DJU (1)). The study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. All identifiers were removed, and data were anonymised before data analysis. The dataset supporting this article\u2019s findings belongs to the Malaysian cervical cancer screening registry by the Family Health Development Division, MOH Malaysia. Requests for the data can be obtained from Dr Zakiah Mohd Said (drzakiahms@moh.gov.my), the head of the Adult Health Sector, Ministry of Health Malaysia, with permission from the Director-General of Health, Malaysia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2243"}}